Associations with QTc interval and atherosclerosis in patients with type 2 diabetes

Associations with QTc interval and atherosclerosis in patients with type 2 diabetes - Associations with QTc interval and atherosclerosis in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040833

Enrollment

200

Registered

2020-07-01

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes who were admitted to Nippon Medical School Hospital for glycemic control during April 2009 to March 2013.

Exclusion criteria

Exclusion criteria: Atrial fibrillation, uncontrolled endocrine disease, receiving steroid therapy, hemodialysis, infection, malignant tumor under treatment and ketoacidosis.

Design outcomes

Primary

Measure	Time frame
QTc interval, ABI, CAVI, Carotid artery ultrasonography, FMD	—

Countries

Japan

Contacts

Public ContactHitoshi Sugihara

Nippon Medical School Hospital Department of Diabetes, Endocrinology and Metabolism

hitoshi@nms.ac.jp03-3822-2131

Outcome results